Answers are grounded in this paper and cite their sources.
These findings build on the work of others in demonstrating strong therapeutic potential for APC in the treatment of inflammatory demyelinating disease and suggest that enhancement of vascular integrity and suppression of microglial activation may be important mediators of this protection.
No takes yet. Share an insight, caveat, or question.
Kant et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: